Real world cost of human epidermal receptor 2-positive metastatic breast cancer patients: a longitudinal incidence-based observational costing study in the Netherlands and Belgium.

GWJ (Geert) Frederix, Hans Severens, AM Hovels, JGC van Hasselt, MJJ Hooiveld, P Neven, JAM Raaijmakers, JHM (Jan) Schellens

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)340-354
Number of pages14
JournalEuropean Journal of Cancer Care
Issue number3
Publication statusPublished - 21 Nov 2014

Research programs

  • EMC NIHES-05-63-02 Quality

Cite this